Not applicableUnknownNCT02172365What this trial is testingAllogeneic SCT for CML, TKI Failure After TKI FailureWho this might be right forChronic Myeloid Leukemia University Health Network, Toronto 350
Not applicableWithdrawnNCT00770419What this trial is testingPerceptions of Burden in Patients With Late-Stage Cancer and Their CaregiversWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more Rutgers, The State University of New Jersey
Not applicableEnded earlyNCT00726830What this trial is testingMethadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00006475What this trial is testingSTI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast CrisisWho this might be right forLeukemia Novartis
Testing effectiveness (Phase 2)Active Not RecruitingNCT01424982What this trial is testingCombination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete Remission+4 more M.D. Anderson Cancer Center 88
Testing effectiveness (Phase 2)Study completedNCT00982488What this trial is testingLong-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Bristol-Myers Squibb 238
Testing effectiveness (Phase 2)Study completedNCT03267186What this trial is testingIbrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell TransplantWho this might be right forAcute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more Andrew Rezvani 8
Testing effectiveness (Phase 2)Ended earlyNCT00006220What this trial is testingArsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous TherapyWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Washington University School of Medicine 5
Not applicableStudy completedNCT00569842What this trial is testingInvestigation of the Cylex® ImmuKnow® AssayWho this might be right forLeukemiaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemia+6 more Indiana University 45
Testing effectiveness (Phase 2)Study completedNCT00003960What this trial is testingDonor Bone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Large-scale testing (Phase 3)Ended earlyNCT00089141What this trial is testingMycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)Who this might be right forCancer Martin, Paul 151
Not applicableStudy completedNCT05260203What this trial is testingMargheRITA (Remote Intelligence for Therapeutic Adherence)Who this might be right forMultiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more Advice Pharma Group srl 124
Testing effectiveness (Phase 2)Study completedNCT00002673What this trial is testingImmunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center 30
Not applicableUnknownNCT02869256What this trial is testingRegional Central Database Recording of Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia Institut Bergonié 400
Testing effectiveness (Phase 2)Ended earlyNCT01621477What this trial is testingT-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic TransplantWho this might be right forAcute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+4 more St. Jude Children's Research Hospital 34
Testing effectiveness (Phase 2)Study completedNCT00539695What this trial is testingLow Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHDWho this might be right forAcute Lymphoblastic LeukemiaALLAcute Myelogenous Leukemia+7 more Baylor College of Medicine 25
Early research (Phase 1)Study completedNCT00003107What this trial is testingInterleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Indiana University
Early research (Phase 1)Study completedNCT00005092What this trial is testingChemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Ended earlyNCT00219765What this trial is testingSafety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous PatientsWho this might be right forChronic Myeloid Leukemia Poitiers University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01660607What this trial is testingPhase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T CellWho this might be right forMyeloid Leukemia, ChronicAcute Myelogenous LeukemiaMyelodysplastic Syndromes (MDS)+6 more Stanford University 68